Cytotoxicity of ascorbic acid in a human colorectal adenocarcinoma cell line (WiDr): In vitro and in vivo studies

Nutrition and Cancer

Volumn 64, Issue 7, 2012, Pages 1049-1057

  Mamede, Ana Catarina ^a,b   Pires, Ana Salomé ^a,c   Abrantes, Ana Margarida ^a   Tavares, Sónia Dorilde ^a,c   Gonçalves, Ana Cristina ^a   Casalta Lopes, João Eduardo ^a   Sarmento Ribeiro, Ana Bela ^a   Maia, Jorge Manuel ^b   Botelho, Maria Filomena ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CLONOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SPECTROPHOTOMETRY; XENOTRANSPLANTATION;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCORBIC ACID; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; DEHYDROASCORBIC ACID; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; MICE; MICE, INBRED BALB C; MITOCHONDRIAL MEMBRANES; SPECTROPHOTOMETRY; TUMOR STEM CELL ASSAY;

EID: 84867765334     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.713539     Document Type: Article

References (34)

1. Winawer, S J. 2007. The multidisciplinary management of gastrointestinal cancer. Colorectal cancer screening. Best Practice & Research. Clinical Gastroenterology, 21: 1031-1048.
2. Potter, J D. 1999. Colorectal cancer: molecules and populations. Journal of the National Cancer Institute, 91: 916-932.
3. Center, M. M, Jemal, A, and, Ward, E. 2009. International trends in colorectal cancer incidence rates. Cancer Epidemiology, Biomarkers & Prevention, 18: 1688-1694.
4. Lee, K W, Lee, H J, Surh, Y-J, and, Lee, C Y. 2003. Vitamin C and cancer chemoprevention: reappraisal. American Journal of Clinical Nutrition, 78: 1074-1078.
5. Deutsch, J C. 2000. Dehydroascorbic acid. Journal of Chromatography, 881: 299-307.
6. Iqbal, K, Khan, A, and, Khattak, M. 2004. Biological Significance of ascorbic acid (vitamin c) in human health: a review. Pakistan Journal of Nutrition, 3: 5-13.
7. Padayatty, S J, Katz, A, Wang, Y, Eck, P, Kwon, O. 2003. Vitamin C as an antioxidant: evaluation of its role in disease prevention. Journal of the American College of Nutrition, 22: 18-35.
8. Mamede, A, Tavares, S, Abrantes, A, Trindade, J, Maia, J. 2011. The role of vitamins in cancer Nutrition and Cancer, 63: 479-494.
9. Padayatty, S J, and, Levine, M. 2001. New insights into the physiology and pharmacology of vitamin C. Canadian Medical Association Journal, 164: 353-355.
10. Li, Y, and, Schellhorn, H E. 2007. New developments and novel therapeutic perspectives for vitamin C. The Journal of Nutrition, 137: 2171-2184.
11. Padayatty, S J, and, Levine, M. 2000. Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity. Journal of the American College of Nutrition, 19: 423-425.
12. Padayatty, S J, Riordan, H D, Hewitt, S M, Katz, A, and, Hoffer, L J. 2006. Intravenously administered vitamin C as cancer therapy: three cases. Canadian Medical Association Journal, 174: 937-942.
13. Chen, Q, Espey, M G, Krishna, M C, Mitchell, J B, Corpe, C P. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, pp. 13604-13609.
14. Valko, M, Leibfritz, D, Moncol, J, Cronin, MTD., Mazur, M. 2007. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology, 39: 44-84.
15. Fruehauf, J P, and, Meyskens, F L. 2007. Reactive oxygen species: a breath of life or death?. Clinical Cancer Research, 13: 789-794.
16. Orrenius, S, Gogvadze, V, and, Zhivotovsky, B. 2007. Mitochondrial oxidative stress: implications for cell death. Annual Review of Pharmacology and Toxicology, 47: 143-183.
17. Valko, M., Rhodes, C J, Moncol, J, Izakovic, M, and, Mazur, M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions, 160: 1-40.
18. Ozben, T. 2007. Oxidative stress and apoptosis: impact on cancer therapy. Journal of Pharmaceutical Sciences, 96: 2181-2196.
19. Ames, B N, Shigenaga, M K, and, Hagen, T M. Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences of the United States of America, Vol. 90, pp. 7915-7922. 17
20. Goodman, M, Bostick, R M, Dash, C, Flanders, W D, and, Mandel, J S. 2007. Hypothesis: oxidative stress score as a combined measure of pro-oxidant and antioxidant exposures. Annals of Epidemiology, 17: 394-399.
21. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65: 55-63.
22. Casalta-Lopes, J, Abrantes, AM, Laranjo, M, Rio, J, Gonalves, AC. 2011. Efflux pumps modulation in colorectal adenocarcinoma cell lines: the role of nuclear medicine. Journal of Cancer Therapy, 2: 408-417.
23. Aubry, J-P, Blaecke, A, Lecoanet-Henchoz, S, Jeannin, P, Herbault, N. 1999. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry, 37: 197-204.
24. Abrantes, A M, Serra, M E, Gonalves, A C, Rio, J, Oliveiros, B. 2010. Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells. Nuclear Medicine and Biology, 37: 125-132.
25. Halliwell, B, and, Whiteman, M. 2004. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. British Journal of Pharmacology, 142: 231-255.
26. Zhao, H, Joseph, J, Fales, HM, Sokoloski, EA, Levine, RL. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, pp. 5727-5732.
27. OConnor, J E, Kimler, B F, Morgan, M C, and, Tempas, K J. 1988. A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry, 9: 529-532.
28. Yao, J, Jiang, Z, Duan, W, Huang, J, Zhang, L. 2008. Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells. Biological & Pharmaceutical Bulletin, 31: 592-597.
29. Dagrosa, M. 2003. Experimental application of boron neutron capture therapy to undifferentiated thyroid carcinoma1. International Journal of Radiation OncologyBiologyPhysics, 57: 1084-1092.
30. Arrigoni, O, and, De Tullio, M C. 2002. Ascorbic acid: much more than just an antioxidant. Biochimica et Biophysica Acta, 1569: 1-9.
31. Giommarelli, C, Corti, A, Supino, R, Favini, E, Paolicchi, A. 2008. Cellular response to oxidative stress and ascorbic acid in melanoma cells overexpressing gamma-glutamyltransferase. European Journal of Cancer, 44: 750-759.
32. Rumsey, S C, Kwon, O, Xu, G W, Burant, C F, Simpson, I. 1997. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. The Journal of Biological Chemistry, 272: 18982-18989.
33. Verrax, J, and, Calderon, P B. 2009. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radical Biology & Medicine, 47: 32-40.
34. Yeom, C-H, Lee, G, Park, JH, Yu, J, Park, S. 2009. High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. Journal of Translational Medicine, 7: 70